Linnaeus Therapeutics

About:

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.

Top Investors: Kairos Ventures, Penn Medicine Co-Investment Program

Description:

Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation.Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016 and is based upon discoveries from the Ridky lab at the University of Pennsylvania.

Total Funding Amount:

$25.5M

Headquarters Location:

Haddonfield, New Jersey, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)linnaeustx.com

Founders:

Christopher Natale, Todd Ridky

Number of Employees:

1-10

Last Funding Date:

2024-08-12

IPO Status:

Private

Industries: